NMRA
Neumora TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
NMRA vs peer average
94/100
NMRA vs. peer average (A vs. D)
Grade spread
A 2 · C 1 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LRMR is the first available peer comparator.
Small-cap clinical-stage CNS biotech with event-driven valuation and financing sensitivity; useful for framing binary readout risk, though not a direct mechanism match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NMRA
Neumora Therapeutics
LRMR
Larimar Therapeutics
Grade
A
D
Momentum
98
2
Value
41
41
Sentiment
74
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs LRMR
NMRA / LRMR
Grade Position
Above peers
NMRA vs. peer average (A vs. D)
94/100
Momentum
98
NMRAValue
41
NMRASentiment
74
LRMRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NMRA
LRMR is the first peer returned for this comparison set.